_id
69105e0dccc777a4e85d58fd
Ticker
DVA
Name
DaVita HealthCare Partners Inc
Exchange
NYSE
Address
2000 16th Street, Denver, CO, United States, 80202
Country
USA
Sector
Healthcare
Industry
Medical Care Facilities
Currency
USD
Website
https://www.davita.com
Description
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
Last Close
118.68
Volume
503450
Current Price
122.38
Change
3.1176272328951704
Last Updated
2025-11-29T12:27:12.339Z
Image
data:image/webp;base64,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
Ipo Date
1995-10-31T00:00:00.000Z
Market Cap
8557120000
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.9884925925925926
Sentiment Sources
27
Rating
3.1
Target Price
144.5
Strong Buy
1
Buy
0
Hold
8
Sell
1
Strong Sell
0
Current Quarter
2025-09-30
Revenue
3420227000
Cost Of Revenue
2332759000
Gross Profit
1087468000
Operating Expenses
581701000
Operating Income
505767000
Interest Expense
150557000
Pretax Income
308803000
Net Income
150332000
Eps
2.037874988138649
Dividends Per Share
-
Shares Outstanding
70600000
Income Tax Expense
68554000
EBITDA
486293000
Operating Margin
14.787527260617498
Total Other Income Expense Net
-196964000
Cash
705960000
Short Term Investments
30524000
Receivables
2855182000
Inventories
139092000
Total Current Assets
4111826000
Property Plant Equipment
5608481000
Total Assets
17743294000
Payables
655598000
Short Term Debt
494936000
Long Term Debt
10183863000
Total Liabilities
16215170000
Equity
-571874000
Depreciation
177490000
Change In Working Capital
461753000
Cash From Operations
841371000
Capital Expenditures
166085000
Cash From Investing
-262940000
Cash From Financing
-581587000
Net Change In Cash
-1545000
PE
12.3509
PB
-15.78643236097462
ROE
-26.287608808933438
ROA
0.847260942641203
FCF
675286000
Fcf Percent
0.19743894191818262
Piotroski FScore
3
Health Score
50
Deep Value Investing Score
4
Defensive Investing Score
8
Dividend Investing Score
3
Economic Moat Investing Score
7.3
Garp Investing Score
2.5
Growth Investing Score
3
Momentum Investing Score
5.5
Net Net Investing Score
2
Quality Investing Score
3.5
Value Investing Score
3
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
3420227000
Quarters > 0 > income Statement > cost Of Revenue
2332759000
Quarters > 0 > income Statement > gross Profit
1087468000
Quarters > 0 > income Statement > operating Expenses
581701000
Quarters > 0 > income Statement > operating Income
505767000
Quarters > 0 > income Statement > interest Expense
150557000
Quarters > 0 > income Statement > pretax Income
308803000
Quarters > 0 > income Statement > net Income
150332000
Quarters > 0 > income Statement > eps
2.037874988138649
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
73769000
Quarters > 0 > income Statement > income Tax Expense
68554000
Quarters > 0 > income Statement > EBITDA
486293000
Quarters > 0 > income Statement > operating Margin
14.787527260617498
Quarters > 0 > income Statement > total Other Income Expense Net
-196964000
Quarters > 0 > balance Sheet > cash
705960000
Quarters > 0 > balance Sheet > short Term Investments
30524000
Quarters > 0 > balance Sheet > receivables
2855182000
Quarters > 0 > balance Sheet > inventories
139092000
Quarters > 0 > balance Sheet > total Current Assets
4111826000
Quarters > 0 > balance Sheet > property Plant Equipment
5608481000
Quarters > 0 > balance Sheet > total Assets
17743294000
Quarters > 0 > balance Sheet > payables
655598000
Quarters > 0 > balance Sheet > short Term Debt
494936000
Quarters > 0 > balance Sheet > long Term Debt
10183863000
Quarters > 0 > balance Sheet > total Liabilities
16215170000
Quarters > 0 > balance Sheet > equity
-571874000
Quarters > 0 > cash Flow > net Income
309548000
Quarters > 0 > cash Flow > depreciation
177490000
Quarters > 0 > cash Flow > change In Working Capital
461753000
Quarters > 0 > cash Flow > cash From Operations
841371000
Quarters > 0 > cash Flow > capital Expenditures
166085000
Quarters > 0 > cash Flow > cash From Investing
-262940000
Quarters > 0 > cash Flow > cash From Financing
-581587000
Quarters > 0 > cash Flow > net Change In Cash
-1545000
Quarters > 0 > ratios > PE
2.037874988138649
Quarters > 0 > ratios > PB
-15.78643236097462
Quarters > 0 > ratios > ROE
-26.287608808933438
Quarters > 0 > ratios > ROA
0.847260942641203
Quarters > 0 > ratios > FCF
675286000
Quarters > 0 > ratios > Piotroski FScore
3
Quarters > 0 > ratios > fcf Percent
0.19743894191818262
Quarters > 0 > health Score
50
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
3379526000
Quarters > 1 > income Statement > cost Of Revenue
2261540000
Quarters > 1 > income Statement > gross Profit
1117986000
Quarters > 1 > income Statement > operating Expenses
580145000
Quarters > 1 > income Statement > operating Income
537841000
Quarters > 1 > income Statement > interest Expense
146062000
Quarters > 1 > income Statement > pretax Income
368928000
Quarters > 1 > income Statement > net Income
199337000
Quarters > 1 > income Statement > eps
2.5766784726351437
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
77362000
Quarters > 1 > income Statement > income Tax Expense
93708000
Quarters > 1 > income Statement > EBITDA
689694000
Quarters > 1 > income Statement > operating Margin
15.91468744433391
Quarters > 1 > income Statement > total Other Income Expense Net
-168913000
Quarters > 1 > balance Sheet > cash
708417000
Quarters > 1 > balance Sheet > short Term Investments
31014000
Quarters > 1 > balance Sheet > receivables
3003226000
Quarters > 1 > balance Sheet > inventories
146295000
Quarters > 1 > balance Sheet > total Current Assets
4087828000
Quarters > 1 > balance Sheet > property Plant Equipment
5193067000
Quarters > 1 > balance Sheet > total Assets
17492958000
Quarters > 1 > balance Sheet > payables
594403000
Quarters > 1 > balance Sheet > short Term Debt
611694000
Quarters > 1 > balance Sheet > long Term Debt
10078805000
Quarters > 1 > balance Sheet > total Liabilities
15939935000
Quarters > 1 > balance Sheet > equity
-369633000
Quarters > 1 > cash Flow > net Income
275220000
Quarters > 1 > cash Flow > depreciation
174704000
Quarters > 1 > cash Flow > change In Working Capital
-171602000
Quarters > 1 > cash Flow > cash From Operations
324394000
Quarters > 1 > cash Flow > capital Expenditures
121091000
Quarters > 1 > cash Flow > cash From Investing
-66745000
Quarters > 1 > cash Flow > cash From Financing
3868000
Quarters > 1 > cash Flow > net Change In Cash
272386000
Quarters > 1 > ratios > PE
2.5766784726351437
Quarters > 1 > ratios > PB
-25.613409949869194
Quarters > 1 > ratios > ROE
-53.92835596388851
Quarters > 1 > ratios > ROA
1.1395271171405088
Quarters > 1 > ratios > FCF
203303000
Quarters > 1 > ratios > Piotroski FScore
3
Quarters > 1 > ratios > fcf Percent
0.06015725282184543
Quarters > 1 > health Score
36
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
3223529000
Quarters > 2 > income Statement > cost Of Revenue
2239660000
Quarters > 2 > income Statement > gross Profit
983869000
Quarters > 2 > income Statement > operating Expenses
544932000
Quarters > 2 > income Statement > operating Income
438937000
Quarters > 2 > income Statement > interest Expense
135055000
Quarters > 2 > income Statement > pretax Income
286333000
Quarters > 2 > income Statement > net Income
162917000
Quarters > 2 > income Statement > eps
2.004515533681944
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
81275000
Quarters > 2 > income Statement > income Tax Expense
54117000
Quarters > 2 > income Statement > EBITDA
597839000
Quarters > 2 > income Statement > operating Margin
13.61666049847853
Quarters > 2 > income Statement > total Other Income Expense Net
-152604000
Quarters > 2 > balance Sheet > cash
438780000
Quarters > 2 > balance Sheet > short Term Investments
73163000
Quarters > 2 > balance Sheet > receivables
2321818000
Quarters > 2 > balance Sheet > inventories
150522000
Quarters > 2 > balance Sheet > total Current Assets
3636188000
Quarters > 2 > balance Sheet > property Plant Equipment
5261885000
Quarters > 2 > balance Sheet > total Assets
17119030000
Quarters > 2 > balance Sheet > payables
596137000
Quarters > 2 > balance Sheet > short Term Debt
599154000
Quarters > 2 > balance Sheet > long Term Debt
9559745000
Quarters > 2 > balance Sheet > total Liabilities
15459061000
Quarters > 2 > balance Sheet > equity
-267101000
Quarters > 2 > cash Flow > net Income
162917000
Quarters > 2 > cash Flow > depreciation
176451000
Quarters > 2 > cash Flow > change In Working Capital
-290151000
Quarters > 2 > cash Flow > cash From Operations
180009000
Quarters > 2 > cash Flow > capital Expenditures
143258000
Quarters > 2 > cash Flow > cash From Investing
-162138000
Quarters > 2 > cash Flow > cash From Financing
-382540000
Quarters > 2 > cash Flow > net Change In Cash
-355252000
Quarters > 2 > ratios > PE
2.004515533681944
Quarters > 2 > ratios > PB
-37.23847720525195
Quarters > 2 > ratios > ROE
-60.994530159003524
Quarters > 2 > ratios > ROA
0.9516719113174054
Quarters > 2 > ratios > FCF
36751000
Quarters > 2 > ratios > Piotroski FScore
3
Quarters > 2 > ratios > fcf Percent
0.011400859120547698
Quarters > 2 > health Score
31
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
3294683000
Quarters > 3 > income Statement > cost Of Revenue
2225371000
Quarters > 3 > income Statement > gross Profit
1069312000
Quarters > 3 > income Statement > operating Expenses
503950000
Quarters > 3 > income Statement > operating Income
565362000
Quarters > 3 > income Statement > interest Expense
138721000
Quarters > 3 > income Statement > pretax Income
413733000
Quarters > 3 > income Statement > net Income
259329000
Quarters > 3 > income Statement > eps
3.0226586630922547
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
85795000
Quarters > 3 > income Statement > income Tax Expense
64488000
Quarters > 3 > income Statement > EBITDA
726556000
Quarters > 3 > income Statement > operating Margin
17.159829944185827
Quarters > 3 > income Statement > total Other Income Expense Net
-151629000
Quarters > 3 > balance Sheet > cash
794933000
Quarters > 3 > balance Sheet > short Term Investments
51064000
Quarters > 3 > balance Sheet > receivables
2530141000
Quarters > 3 > balance Sheet > inventories
134559000
Quarters > 3 > balance Sheet > total Current Assets
3746072000
Quarters > 3 > balance Sheet > property Plant Equipment
5744885000
Quarters > 3 > balance Sheet > total Assets
17285268000
Quarters > 3 > balance Sheet > payables
547200000
Quarters > 3 > balance Sheet > short Term Debt
681278000
Quarters > 3 > balance Sheet > long Term Debt
9175903000
Quarters > 3 > balance Sheet > total Liabilities
15193917000
Quarters > 3 > balance Sheet > equity
121122000
Quarters > 3 > cash Flow > net Income
349245000
Quarters > 3 > cash Flow > depreciation
174102000
Quarters > 3 > cash Flow > change In Working Capital
61336000
Quarters > 3 > cash Flow > cash From Operations
547627000
Quarters > 3 > cash Flow > capital Expenditures
170657000
Quarters > 3 > cash Flow > cash From Investing
-247974000
Quarters > 3 > cash Flow > cash From Financing
-565103000
Quarters > 3 > cash Flow > net Change In Cash
-278819000
Quarters > 3 > ratios > PE
3.0226586630922547
Quarters > 3 > ratios > PB
86.68608592988888
Quarters > 3 > ratios > ROE
214.10561252291077
Quarters > 3 > ratios > ROA
1.5002891479611424
Quarters > 3 > ratios > FCF
376970000
Quarters > 3 > ratios > Piotroski FScore
4
Quarters > 3 > ratios > fcf Percent
0.11441768449347024
Quarters > 3 > health Score
51
Valuation > metrics > PE
12.3509
Valuation > metrics > PB
-15.78643236097462
Valuation > final Score
80
Valuation > verdict
Fair
Profitability > metrics > ROE
-26.287608808933438
Profitability > metrics > ROA
3.6560885601676723
Profitability > metrics > Net Margin
0.043953807744339775
Profitability > final Score
18
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
3.359305777878146
Risk > final Score
43
Risk > verdict
High
Liquidity > metrics > Current Ratio
3.5738413640970195
Liquidity > metrics > Quick Ratio
3.4529479354803945
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
40
Prev Profitabilities > 0
23
Prev Profitabilities > 1
21
Prev Profitabilities > 2
73
Prev Risks > 0
45
Prev Risks > 1
43
Prev Risks > 2
22
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-12T00:18:18.406Z
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
Stock Price
$ 0.00
0% increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AAvoiding Lag: Real-Time Signals in (DVA) Movement news.stocktradersdaily.com
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
HOLD
Target Price:
$144.5
Analyst Picks
Strong Buy
1
Buy
0
Hold
8
Sell
1
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Earnings Ratio (P/E)
-
Very High
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very High
Low ≤ 5%
High ≥ 15%
* Institutions hold a combined 92.71% of the total shares of DaVita HealthCare Partners Inc
1.
Berkshire Hathaway Inc(47.2679%)
since
2025/06/30
2.
Vanguard Group Inc(6.6399%)
since
2025/06/30
3.
BlackRock Inc(5.7529%)
since
2025/06/30
4.
State Street Corp(2.9277%)
since
2025/06/30
5.
Amvescap Plc.(2.3033%)
since
2025/06/30
6.
Morgan Stanley - Brokerage Accounts(2.1673%)
since
2025/06/30
7.
Vanguard Total Stock Mkt Idx Inv(1.6526%)
since
2025/07/31
8.
Geode Capital Management, LLC(1.552%)
since
2025/06/30
9.
Gates Capital Management Inc(1.537%)
since
2025/06/30
10.
Vanguard 500 Index Investor(1.438%)
since
2025/07/31
11.
Invesco S&P 500® Equal Weight ETF(1.4321%)
since
2025/08/29
12.
Dimensional Fund Advisors, Inc.(1.3951%)
since
2025/06/30
13.
LSV Asset Management(1.3157%)
since
2025/06/30
14.
Vanguard Small Cap Index(1.2819%)
since
2025/07/31
15.
Northern Trust Corp(1.003%)
since
2025/06/30
16.
Vanguard Small Cap Value Index Inv(0.8258%)
since
2025/07/31
17.
UBS Group AG(0.7919%)
since
2025/06/30
18.
Fidelity 500 Index(0.7362%)
since
2025/07/31
19.
Squarepoint Ops LLC(0.705%)
since
2025/06/30
20.
SPDR® S&P 500® ETF(0.7029%)
since
2025/08/31
21.
iShares Core S&P 500 ETF(0.6997%)
since
2025/08/31
22.
JPMorgan Chase & Co(0.6764%)
since
2025/06/30
23.
Pacer Advisors, INC.(0.6525%)
since
2025/06/30
24.
BlackRock Systematic Multi-Strat Instl(0.6524%)
since
2025/06/30
25.
Royal Bank of Canada(0.6419%)
since
2025/06/30
26.
Amundi(0.641%)
since
2025/06/30
27.
Charles Schwab Investment Management Inc(0.6224%)
since
2025/06/30
28.
UBS Asset Mgmt Americas Inc(0.596%)
since
2025/06/30
29.
Millennium Management LLC(0.5869%)
since
2025/06/30
30.
Pacer US Small Cap Cash Cows 100 ETF(0.5752%)
since
2025/08/29
31.
The Health Care Select Sector SPDR® ETF(0.3965%)
since
2025/08/31
32.
iShares Russell Mid-Cap Growth ETF(0.3516%)
since
2025/08/31
33.
Vanguard Institutional Index I(0.3505%)
since
2025/07/31
34.
Neuberger Berman Quality Equity Inv(0.3413%)
since
2025/07/31
35.
State St S&P 500® Indx SL Cl III(0.31%)
since
2025/08/31
36.
WEDGE QVM Large Cap Value(0.3006%)
since
2025/03/31
37.
Blackrock Eq Idx Fund CF(0.2316%)
since
2025/06/30
38.
Vanguard Institutional 500 Index Trust(0.2218%)
since
2025/07/31
39.
DFA US Core Equity 2 I(0.2181%)
since
2025/07/31
40.
TD US Large-Cap Value - A(0.2172%)
since
2024/12/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.